Tackling challenges of TB/MDRTB in China: concerted actions are imperative

doi:10.1186/s40249-015-0050-4

. 2015 Apr 16:4:19.

doi: 10.1186/s40249-015-0050-4. eCollection 2015.

Tackling challenges of TB/MDRTB in China: concerted actions are imperative

Shenglan Tang¹

Affiliations

PMID: 25908975
PMCID: PMC4407541
DOI: 10.1186/s40249-015-0050-4

Tackling challenges of TB/MDRTB in China: concerted actions are imperative

Shenglan Tang. Infect Dis Poverty. 2015.

. 2015 Apr 16:4:19.

doi: 10.1186/s40249-015-0050-4. eCollection 2015.

Author

Shenglan Tang¹

Affiliation

¹ Duke Global Health Institute, Duke University, Durham, USA ; Duke Kunshan University, Global Health Research Center, Kunshan, China.

PMID: 25908975
PMCID: PMC4407541
DOI: 10.1186/s40249-015-0050-4

Abstract

China is the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR). Over the past decade, a large number of TB control projects have been funded by the government of China and international organizations, and epidemic in China has been effectively controlled. However TB control in China still faced many challenges. Strategies to address these challenges may include integrating the national TB control program into health insurance schemes, strengthening TB case management through involving the Chinese hospital in national TB control program, and reforming payment methods for TB care as part of health system reform in China.

Keywords: China; Tuberculosis.

PubMed Disclaimer

Cited by

Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.
Wang XX, Chen JY, Jiang H, Zhu AN, Long Q, Ji JS. Wang XX, et al. Infect Dis Poverty. 2019 Oct 4;8(1):79. doi: 10.1186/s40249-019-0590-0. Infect Dis Poverty. 2019. PMID: 31581953 Free PMC article.
The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients.
Xin YJ, Xiang L, Jiang JN, Lucas H, Tang SL, Huang F. Xin YJ, et al. Infect Dis Poverty. 2019 Aug 2;8(1):67. doi: 10.1186/s40249-019-0575-z. Infect Dis Poverty. 2019. PMID: 31370909 Free PMC article.
Spatial transmission and meteorological determinants of tuberculosis incidence in Qinghai Province, China: a spatial clustering panel analysis.
Rao HX, Zhang X, Zhao L, Yu J, Ren W, Zhang XL, Ma YC, Shi Y, Ma BZ, Wang X, Wei Z, Wang HF, Qiu LX. Rao HX, et al. Infect Dis Poverty. 2016 Jun 2;5(1):45. doi: 10.1186/s40249-016-0139-4. Infect Dis Poverty. 2016. PMID: 27251154 Free PMC article.
Impact of an innovative financing and payment model on tuberculosis patients' financial burden: is tuberculosis care more affordable for the poor?
Jiang WX, Long Q, Lucas H, Dong D, Chen JY, Xiang L, Li Q, Huang F, Wang H, Elbers C, Cobelens F, Tang SL. Jiang WX, et al. Infect Dis Poverty. 2019 Mar 24;8(1):21. doi: 10.1186/s40249-019-0532-x. Infect Dis Poverty. 2019. PMID: 30904025 Free PMC article.
Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China.
Pan Y, Chen S, Chen M, Zhang P, Long Q, Xiang L, Lucas H. Pan Y, et al. Infect Dis Poverty. 2016 Jan 27;5:7. doi: 10.1186/s40249-016-0102-4. Infect Dis Poverty. 2016. PMID: 26812914 Free PMC article.

See all "Cited by" articles

References

1. World Health Organization. Global tuberculosis report 2014. [http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?...]
1. World Health Organization. Drug-resistant tuberculosis--surveillance & response. [http://apps.who.int/iris/bitstream/10665/137095/1/WHO_HQ_TB_2014.12_eng....]
1. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161–70. doi: 10.1056/NEJMoa1108789. - DOI - PubMed
1. Li WB, Zhang YQ, Xing J, Ma ZY, Qu YH, Li XX. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan province, China. Infect Dis Poverty. 2015;4:14. doi: 10.1186/s40249-015-0045-1. - DOI - PMC - PubMed
1. Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156. doi: 10.1186/1741-7015-11-156. - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

[1] World Health Organization. Global tuberculosis report 2014. [http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?...]

[2] World Health Organization. Global tuberculosis report 2014. [http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?...]

[3] World Health Organization. Drug-resistant tuberculosis--surveillance & response. [http://apps.who.int/iris/bitstream/10665/137095/1/WHO_HQ_TB_2014.12_eng....]

[4] World Health Organization. Drug-resistant tuberculosis--surveillance & response. [http://apps.who.int/iris/bitstream/10665/137095/1/WHO_HQ_TB_2014.12_eng....]

[5] Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161–70. doi: 10.1056/NEJMoa1108789. - DOI - PubMed

[6] Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161–70. doi: 10.1056/NEJMoa1108789. - DOI - PubMed

[7] Li WB, Zhang YQ, Xing J, Ma ZY, Qu YH, Li XX. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan province, China. Infect Dis Poverty. 2015;4:14. doi: 10.1186/s40249-015-0045-1. - DOI - PMC - PubMed

[8] Li WB, Zhang YQ, Xing J, Ma ZY, Qu YH, Li XX. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan province, China. Infect Dis Poverty. 2015;4:14. doi: 10.1186/s40249-015-0045-1. - DOI - PMC - PubMed

[9] Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156. doi: 10.1186/1741-7015-11-156. - DOI - PMC - PubMed

[10] Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156. doi: 10.1186/1741-7015-11-156. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Tackling challenges of TB/MDRTB in China: concerted actions are imperative

Affiliation

Tackling challenges of TB/MDRTB in China: concerted actions are imperative

Author

Affiliation

Abstract

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous